Prasco Laboratories to Distribute Wyeth's Own Generic Versions of Protonix(R) Delayed-Release Tablets

CINCINNATI--(BUSINESS WIRE)--Prasco announced today that, pursuant to an agreement it entered into with the ESI Lederle Division of Wyeth (“ESI”), it is shipping the generic version of PROTONIX® (Pantoprazole Sodium) Delayed-Release Tablets being offered for sale by ESI. Prasco, as ESI’s agent and on ESI’s behalf, will solicit orders for and distribute the 20 mg and 40 mg formulations of Pantoprazole Sodium Delayed-Release (DR) Tablets to all trade classes in the U.S. under the ESI Lederle label. Pantoprazole Sodium DR Tablets are AB-rated, therapeutically equivalent and substitutable for the brand PROTONIX Delayed-Release (DR) Tablets.